{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:17:49Z","timestamp":1787170669579,"version":"build-2736575974"},"reference-count":58,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Treatment for immune thrombocytopenia (ITP) in pregnancy is hampered by the lack of fetal safety evidence of maternally\u2010administered medications. The Pregnancy Surveillance Program (PSP) collected patient information from 2017\u20132020 for pregnancy, birth outcomes, and adverse events (AEs) for 186 women exposed to romiplostim from 20\u2009days before pregnancy to the end of pregnancy. Timing of exposure was available in 128 women. Seventy\u2010one mothers (38%) had prepregnancy exposure to romiplostim; intrapartum exposure was known for the first (for many mothers when they discovered their pregnancy), second, and third trimesters for 74 (40%), 22 (12%), and 44 (24%) mothers, respectively, with 15 mothers exposed during &gt;1 trimester. Among the 86 mothers with known pregnancy outcomes, 46 (53%) had at least one pregnancy\u2010related serious AE (SAE); approximately 2\/3 of SAEs were due to underlying ITP. Of 92 mothers with known birth outcomes, 60 (65%) had a normal pregnancy and 16 (17%) had complications, with both categories including term and preterm births; there were 12 (14%) spontaneous miscarriages\/stillbirths, 3 (3%) ectopic pregnancies, and 1 (1%) molar pregnancy. Most abnormal births resulted from abnormal pregnancies. There were five neonatal\/postnatal AEs of note: inguinal hernia, cytomegalovirus infection, trisomy 8 (third trimester single\u2010dose romiplostim exposure), single umbilical artery without known anomalies, and development of autism at age 2\u2009years. Seven of 12 infants with neonatal thrombocytopenia had resolution of thrombocytopenia before discharge; all 12 were discharged. Review of pregnancies in women exposed to romiplostim did not reveal any specific safety concerns for mothers, fetuses, or infants.<\/jats:p>","DOI":"10.1002\/ajh.26743","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T03:23:25Z","timestamp":1664162605000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Romiplostim use in pregnant women with immune thrombocytopenia"],"prefix":"10.1002","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2884-9247","authenticated-orcid":false,"given":"James B.","family":"Bussel","sequence":"first","affiliation":[{"name":"Weill Cornell Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-8292","authenticated-orcid":false,"given":"Nichola","family":"Cooper","sequence":"additional","affiliation":[{"name":"Hammersmith Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Amgen Inc.  Thousand Oaks California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-7400","authenticated-orcid":false,"given":"Marc","family":"Michel","sequence":"additional","affiliation":[{"name":"Henri Mondor University Hospital Universit\u00e9 Paris\u2010Est Cr\u00e9teil  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Vander Haar","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Wang","sequence":"additional","affiliation":[{"name":"Amgen Inc.  Thousand Oaks California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Amgen Inc.  Thousand Oaks California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Saad","sequence":"additional","affiliation":[{"name":"Amgen Inc.  Thousand Oaks California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162503"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781971"},{"key":"e_1_2_10_4_1","unstructured":"RajasekharA GernsheimerT StasiR JamesAH.2013 Clinical Practice Guide on Thrombocytopenia in Pregnancy.https:\/\/prd\u2010medweb\u2010cdn.s3.amazonaws.com\/documents\/vmcpathology\/files\/2013\u2010Thrombocytopenia\u2010Pocket\u2010Guide.pdf 2022."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000758"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92228-T"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007263230404"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-710285"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20160253"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06339.x"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054626"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0361-y"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28630"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25136"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-313908"},{"key":"e_1_2_10_18_1","unstructured":"Nplate\u00ae (romiplostim) injection for subcutaneous use [prescribing information].2022.https:\/\/www.pi.amgen.com\/~\/media\/amgen\/repositorysites\/pi-amgen-com\/nplate\/nplate_pi_hcp_english.pdf."},{"key":"e_1_2_10_19_1","unstructured":"Nplate\u00ae (romiplostim) summary of product characteristics (EU) 2022.https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/nplate\u2010epar\u2010product\u2010information_en.pdf 2022."},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X18773960"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007594"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1615613"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2014.05.003"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2014.05.004"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12798"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2015.10.015"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.06.005"},{"key":"e_1_2_10_28_1","volume-title":"StatPearls","author":"Habak P","year":"2022"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003891"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5151.119196"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"e_1_2_10_32_1","unstructured":"Centers for Disease Control and Prevention: Diabetes during pregnancy.https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/diabetes-during-pregnancy.htm 2022."},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12968"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.913130"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30592-2"},{"issue":"47","key":"e_1_2_10_36_1","first-page":"795","article-title":"The differential diagnosis of thrombocytopenia in pregnancy","volume":"112","author":"Bergmann F","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802897"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8297407"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/14767050903029592"},{"issue":"2","key":"e_1_2_10_40_1","first-page":"76","article-title":"Recurrent pregnancy loss: etiology, diagnosis, and therapy","volume":"2","author":"Ford HB","year":"2009","journal-title":"Rev Obstet Gynecol"},{"issue":"7","key":"e_1_2_10_41_1","first-page":"1243","article-title":"Management of spontaneous abortion","volume":"72","author":"Griebel CP","year":"2005","journal-title":"Am Fam Physician"},{"issue":"8","key":"e_1_2_10_42_1","first-page":"1","article-title":"Fetal and perinatal mortality: United States, 2013","volume":"64","author":"MacDorman MF","year":"2015","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62233-7"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40738-015-0008-z"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.08.022"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.18.6.570"},{"issue":"1","key":"e_1_2_10_47_1","first-page":"1","article-title":"Update on overall prevalence of major birth defects\u2013Atlanta, Georgia, 1978\u20132005","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-017-0358-8"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01658863"},{"issue":"1","key":"e_1_2_10_50_1","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.4103\/0975-7406.155815","article-title":"Single umbilical artery","volume":"7","author":"Ramesh S","year":"2015","journal-title":"J Pharm Bioallied Sci"},{"key":"e_1_2_10_51_1","unstructured":"Genetic and Rare Diseases Information Center.Mosaic trisomy 8.0https:\/\/rarediseases.info.nih.gov\/diseases\/5359\/mosaic\u2010trisomy\u20108. Accessed February 17 2022."},{"key":"e_1_2_10_52_1","first-page":"1","article-title":"Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey","volume":"87","author":"Zablotsky B","year":"2015","journal-title":"Natl Health Stat Rep"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2011.07.008"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292005"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761262"},{"key":"e_1_2_10_56_1","doi-asserted-by":"crossref","first-page":"e00281","DOI":"10.1016\/j.crwh.2020.e00281","article-title":"Eltrombopag use for refractory immune thrombocytopenia in pregnancy: a case report","volume":"29","author":"Weingarten SJ","year":"2021","journal-title":"Case Rep Womens Health"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2383-1"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.177204"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2018.06.010"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26743","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.26743","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T05:05:43Z","timestamp":1692421543000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.26743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/ajh.26743"],"URL":"https:\/\/doi.org\/10.1002\/ajh.26743","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"2022-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}